The Allstate Co. (NYSE:ALL) CFO Sells $7,480,226.06 in Stock

The Allstate Co. (NYSE:ALL - Get Free Report) CFO Jesse E. Merten sold 40,102 shares of the firm's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the completion of the transaction, the chief financial officer now owns 18,115 shares in the company, valued at $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Allstate Price Performance

Shares of NYSE:ALL traded down $5.24 during midday trading on Friday, reaching $187.53. 3,917,486 shares of the company's stock were exchanged, compared to its average volume of 1,603,816. The company's 50 day simple moving average is $190.91 and its two-hundred day simple moving average is $189.74. The firm has a market capitalization of $49.66 billion, a PE ratio of 11.04, a price-to-earnings-growth ratio of 1.47 and a beta of 0.52. The Allstate Co. has a 12 month low of $153.87 and a 12 month high of $209.88. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. Equities research analysts expect that The Allstate Co. will post 18.64 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ALL has been the topic of a number of research analyst reports. Barclays lowered their target price on shares of Allstate from $187.00 to $183.00 and set an "underweight" rating on the stock in a research note on Monday, January 6th. Evercore ISI upgraded shares of Allstate from an "in-line" rating to an "outperform" rating in a research note on Wednesday, January 8th. Wells Fargo & Company raised their target price on shares of Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a research note on Tuesday, January 14th. Piper Sandler raised their target price on shares of Allstate from $206.00 to $244.00 and gave the company an "overweight" rating in a research note on Tuesday, November 26th. Finally, Jefferies Financial Group increased their price target on shares of Allstate from $231.00 to $267.00 and gave the company a "buy" rating in a report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $217.94.

Hedge Funds Weigh In On Allstate

Several institutional investors have recently added to or reduced their stakes in the company. VSM Wealth Advisory LLC acquired a new stake in Allstate in the 4th quarter valued at about $25,000. FSA Wealth Management LLC acquired a new stake in Allstate in the 3rd quarter valued at about $26,000. Twin Tree Management LP acquired a new stake in Allstate in the 4th quarter valued at about $27,000. Northwest Investment Counselors LLC acquired a new stake in Allstate in the 3rd quarter valued at about $28,000. Finally, Vision Financial Markets LLC acquired a new stake in Allstate in the 4th quarter valued at about $29,000. 76.47% of the stock is owned by institutional investors.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.